Biotin

Biotin

SCHEMBL15067659

N[C@@H](Cc1cnc[nH]1)C(=O)O.O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 6/20 0.62
▸ MEN1 O00255 1/20 0.62
▸ ABL1 P00519 1/20 0.62
▸ LMNA P02545 1/20 0.62
▸ PKM P14618 1/20 0.62
▸ IDE P14735 1/20 0.62
▸ MAPK1 P28482 1/20 0.62
▸ KMT2A Q03164 1/20 0.62
▸ RIN1 Q13671 1/20 0.62
▸ L3MBTL1 Q9Y468 1/20 0.62
▸ CYP3A4 P08684 1/20 0.51
▸ SLC7A5 Q01650 1/20 0.51
▸ HLCS P50747 3/20 0.45
▸ CA12 O43570 6/20 0.44
▸ CA1 P00915 6/20 0.44
▸ CA2 P00918 6/20 0.44
▸ CA9 Q16790 6/20 0.44
▸ FOLH1 Q04609 2/20 0.42
▸ PLCG1 P19174 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27897881 0.86 TDP1 (0.53) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL8366189 0.82 TDP1 (0.68) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL6734256 0.82 TDP1 (0.62) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL20495575 0.82 TDP1 (0.62) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL15067661 0.82 TDP1 (0.62) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL5903513 0.81 TDP1 (0.77) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL8011738 0.81 TDP1 (0.77) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL5903509 0.81 TDP1 (0.77) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL8011736 0.81 TDP1 (0.77) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL10618578 0.80 TDP1 (0.65) TDP1MEN1ABL1LMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103524373-B Polyamines aryl buserelin chemical families, and cosmetics or cosmetics for skin application 爱西美有限公司 2016-12-28 — — CN disclosed
US-8993611-B2 Family of polyamine arylethylamide compounds, and their cosmetic or dermocosmetic use EXSYMOL (MC) 2015-03-31 — — US disclosed
CN-103524373-A Polyamine aryl ethyl amide compound family and cosmetic applications or skin cosmetic applications thereof EXSYMOL SA 2014-01-22 — — CN disclosed
US-20140005244-A1 FAMILY OF POLYAMINE ARYLETHYLAMIDE COMPOUNDS, AND THEIR COSMETIC OR DERMOCOSMETIC USE EXSYMOL (MC) 2014-01-02 — — US disclosed
WO-2013098743-A1 COMPOSITION FOR A MEDICAL DEVICE OR FOR A COSMETIC OR PHARMACEUTICAL PREPARATION COMPRISING A DECAPEPTIDE DERIVED FROM DEINOCOCCUS RADIODURANS BIODUE S.P.A. (IT) 2013-07-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140005244-A1 FAMILY OF POLYAMINE ARYLETHYLAMIDE COMPOUNDS, AND THEIR COSMETIC OR DERMOCOSMETIC USE UNG, DPM1, SRM TDP1 287/4885MEN1 1435/4885ABL1 4210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback